The cannabinoid receptor type two is a therapeutic target for muscular dystrophy cardiomyopathy.

20 April 2018 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: All day Poster Session - Basic Science - Cardiac Biology and Physiology Stem Cells, Cell Cycle, Cell Senescence, Cell Death Open Access Frontiers in CardioVascular Biology 2018 Council on Basic Cardiovascular Science

ESC 365 is supported by

ESC 365 is supported by